Table 1 Long-term outcome parameters (N = 228)
Sex | |
Female | 96 (42.1%) |
Age | |
Mean 72.4 ± 12.2 [min 29; max 97], median 73 years | |
Interview partner | |
Patient | 146 (64.0%) |
Family member | 81 (35.5%) |
Caregiver | 1 (0.4%) |
Interval between stroke and telephone interview | |
949.6 ± 358.9 days [min 303; max 2082 days]; median 906 days (= 2.5 years) | |
Long-term outcome of stroke (N = 206) | |
mRS at telephone interview | 2.0 ± 1.9 (median 1) |
Mobility EQ-5D-5L | 2.0 ± 1.4 (median 1) |
Self-care EQ-5D-5L | 1.7 ± 1.3 (median 1) |
Usual activities EQ-5D-5L | 1.9 ± 1.4 (median 1) |
Pain/Discomfort EQ-5D-5L | 1.7 ± 1.1 (median 1) |
Anxiety/Depression EQ-5D-5L | 1.7 ± 1.0 (median 1) |
EQ-5D VAS | 64.5 ± 21.0 (median 70) |
EQ-5D-Index | 0.777 ± 0.287 (median 0.915) |
German level of care before stroke event (N = 205) | |
Level 0 | 180 (87.8%) |
Level 1 | 3 (1.5%) |
Level 2 | 13 (6.3%) |
Level 3 | 6 (2.9%) |
Level 4 | 3 (1.5%) |
Level 5 | 0 (0%) |
German level of care at telephone interview (N = 176) | |
Level 0 | 109 (61.9%) |
Level 1 | 12 (6.8%) |
Level 2 | 19 (10.8%) |
Level 3 | 19 (10.8%) |
Level 4 | 13 (7.4%) |
Level 5 | 4 (2.3%) |
Living situation (N = 206) | |
Independent | 145 (70.4%) |
Support from relatives or partner | 29 (14.1%) |
Care assistance at home | 16 (7.8%) |
Sheltered housing | 5 (2.4%) |
Care home | 11 (5.3%) |
Professional activity (N = 206) | |
Unchanged after stroke | 26 (12.6%) |
Reduced due to stroke event | 12 (5.8%) |
No longer employed due to stroke event | 8 (3.9%) |
Retired (regardless of stroke event or retired before stroke event) | 160 (77.7%) |
Recurrence of stroke (N = 214) | |
Recurrence | 28 (13.1%) |
No recurrence | 186 (86.9%) |
Unknown | 14 |
Therapy | |
Antiplatelet drugs | 133/196 (67.9%) |
Statin therapy | 150/196 (76.5%) |
Oral anticoagulation | 57/196 (29.1%) |
Phenprocoumon | 4/57 |
Apixaban | 35/57 |
Dabigatran | 9/57 |
Edoxaban | 3/57 |
Rivaroxaban | 5/57 |
Unknown | 1/57 |
Antihypertensive therapy | 163/196 (83.2%) |
Antidepressive therapy | 31/196 (15.8%) |
Anticonvulsive therapy | 9/196 (4.6%) |
After discharge hospitalization for other reasons (N = 199) | |
Yes | 61/199 (30.7%) |
Died after discharge | |
Yes | 22/228 (9.6%) |